# A Pilot Study of KPL-914 in Recurrent Pericarditis

> **NCT03980522** · PHASE2 · COMPLETED · sponsor: **Kiniksa Pharmaceuticals (UK), Ltd.** · enrollment: 26 (actual)

## Conditions studied

- Recurrent Pericarditis

## Interventions

- **DRUG:** KPL-914

## Key facts

- **NCT ID:** NCT03980522
- **Lead sponsor:** Kiniksa Pharmaceuticals (UK), Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-24
- **Primary completion:** 2019-05-17
- **Final completion:** 2019-05-17
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2021-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03980522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03980522, "A Pilot Study of KPL-914 in Recurrent Pericarditis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03980522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*